Preview: Os Therapies Incorporated Set To IPO Tomorrow
Portfolio Pulse from Benzinga Insights
OS Therapies Incorporated (NYSE:OSTX) is set to IPO on June 27 on the NYSE, offering shares at $4.00 each. The insider lock-up period will last 180 days, ending on December 24, 2024. The company focuses on treatments for osteosarcoma and other solid tumors.
June 26, 2024 | 3:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
OS Therapies Incorporated is launching its IPO on June 27 at $4.00 per share. The company specializes in treatments for osteosarcoma and other solid tumors. The insider lock-up period will last 180 days, ending on December 24, 2024.
The IPO of OS Therapies Incorporated is likely to generate significant interest due to its focus on biopharmaceutical treatments for osteosarcoma and other solid tumors. The set price of $4.00 per share and the insider lock-up period ending on December 24, 2024, are key details for potential investors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100